SAMHD1 and diffuse large B-cell lymphoma: Higher SAMHD1 expressing DLBCL cells’ sensitivity to doxorubicin following siRNA-mediated SAMHD1 degradation was confirmed by an AlamarBlue-based cell viability assay (Supplementary Figure S2G–I).